Skip to main content
. 2019 Jun 25;10:665. doi: 10.3389/fphys.2019.00665

FIGURE 7.

FIGURE 7

Salidroside inhibiting proteolytic pathways might be through inhibiting IL6 in muscle. (A) Representative blots of Atrogin-1, MuRF1, LC3B and PINK1 in TA muscles treated with salidroside and anti-IL6. (B) Relative expression of Atrogin-1, MuRF1, LC3B and PINK1 in TA muscles treated with salidroside and anti-IL6 (n = 6 rats in each group). ∗∗p < 0.05 versus Ctrl. #p < 0.05 and ##p < 0.01 versus Den.